Syndesi Therapeutics
Emmanuel is Vice President and Partner at UCB Ventures. Previously, Emmanuel was Head of Business Development Neurology at UCB, where he had responsibility for partnering and product licensing/acquisitions in Neurology. Previously in Sales & Global Marketing from 2007 to 2008, Emmanuel contributed to the coordination of global pre-launch activities for Vimpat® and the business planning for UCB’s other CNS products.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Syndesi Therapeutics
Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.